the safety and efficacy of isatuximab for r/r myeloma: insights from icaria-mm, ikema & candor
Published 2 years ago • 195 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
1:45
real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in r/r multiple myeloma
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
3:02
real-world safety and efficacy of cilta-cel in r/r multiple myeloma
-
1:57
the safety and efficacy of iberdomide for the treatment of multiple myeloma
-
1:24
the safety and efficacy of elotuzumab for the treatment of multiple myeloma
-
3:22
vaccine safety in the immunocompromised
-
3:25
belantamab mafodotin and its place in myeloma treatment
-
35:48
control sections for ihc and if applications
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
1:22
safety and efficacy of cesnicabtagene autoleucel (ari0002h) for r/r mm
-
4:17
evaluating the safety and efficacy of elranatamab in multiple myeloma
-
1:57
safety and efficacy of sx-682 in hma failure mds
-
5:35
safety & efficacy of cesnicabtagene autoleucel (ari0002h) in r/r multiple myeloma
-
2:28
the safety and efficacy of selinexor for the treatment of myeloma
-
3:41
emerging therapies for r/r myeloma
-
1:08
safety and efficacy of iberdomide dexamethasone in patients with triple-class refractory myeloma
-
3:09
an overview of the toxicities associated with immunotherapy in multiple myeloma
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
1:15
safety & efficacy of bispecific antibodies in multiple myeloma: teclistamab & elranatamb